Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells.
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells.
复制标题
Zeste同源物2(EZH2)增强子的抑制剂激活人类癌细胞中的肿瘤抑制剂。
DOI:
10.1038/oncsis.2014.17
复制
发表时间:
2014-05-26
期刊:
影响因子:
6.2
通讯作者:
Saito, H.
中科院分区:
文献类型:
--
作者:
Hibino, S.;Saito, Y.;Muramatsu, T.;Otani, A.;Kasai, Y.;Kimura, M.;Saito, H.
Enhancer of zeste homolog 2 (EZH2) enhances tumorigenesis and is commonly overexpressed in several types of cancer. To investigate the anticancer effects of EZH2 inhibitors, microRNA (miRNA) expression profiles were examined in gastric and liver cancer cells treated with suberoylanilide hydroxamic acid (SAHA) and 3-deazaneplanocin A (DZNep). We confirmed that SAHA and DZNep suppressed EZH2 expression in AGS and HepG2 cells and inhibited their proliferation. The results of microarray analyses demonstrated that miR-1246 was commonly upregulated in cancer cells by treatment with SAHA and DZNep. MiR-302a and miR-4448 were markedly upregulated by treatment with SAHA and DZNep, respectively. DYRK1A, CDK2, BMI-1 and Girdin, which are targets of miR-1246, miR-302a and miR-4448, were suppressed by treatment with SAHA and DZNep, leading to apoptosis, cell cycle arrest and reduced migration of AGS and HepG2 cells. ChIP assay revealed that SAHA and DZNep inhibited the binding of EZH2 to the promoter regions of miR-1246, miR-302a and miR-4448. These findings suggest that EZH2 inhibitors such as SAHA and DZNep exert multiple anticancer effects through activation of tumor-suppressor miRNAs.
登录
查看更多内容
影响因子:
8
作者:
Saito, Y.;Suzuki, H.;Hibi, T.
通讯作者:
Hibi, T.
影响因子:
3.7
作者:
Saito Y;Saito H
通讯作者:
Saito H
影响因子:
50.3
作者:
Chang CJ;Yang JY;Xia W;Chen CT;Xie X;Chao CH;Woodward WA;Hsu JM;Hortobagyi GN;Hung MC
通讯作者:
Hung MC
影响因子:
11.2
作者:
Chen, Hsin-Yi;Lin, Yu-Min;Chen, Ruey-Hwa
通讯作者:
Chen, Ruey-Hwa
影响因子:
4.5
作者:
Lin, Shi-Lung;Chang, Donald C.;Ying, Shao-Yao
通讯作者:
Ying, Shao-Yao